We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Enzyme Responsible for Skin Thickening Disorder Linked to Esophageal Cancer

By LabMedica International staff writers
Posted on 17 Feb 2017
Print article
Image: A photomicrograph of keratin filaments inside cells (Photo courtesy of Wikimedia Commons).
Image: A photomicrograph of keratin filaments inside cells (Photo courtesy of Wikimedia Commons).
A recent paper explained the molecular mechanism underlying the development of palmoplantar keratoderma (thickening of the skin on the palms of the hands and soles of the feet) in the rare genetic disease Tylosis with esophageal cancer (TOC).

This condition is inherited as an autosomal dominant syndrome and is characterized by palmoplantar keratoderma, oral precursor lesions particularly on the gums (leukoplakia), and a high lifetime risk of esophageal cancer (95% develop esophageal cancer by the age of 65).

Investigators at Queen Mary University of London reported in the January 27, 2017, online edition of the journal Nature Communications, that the inactive rhomboid protease RHBDF2 (Rhomboid family member 2 - the alternative name iRhom2 has been proposed, in order to clarify that it is a catalytically inactive member of the rhomboid family of intramembrane serine proteases) regulates thickening of the footpad epidermis through its interaction with keratin 16 (K16). K16 is a cytoskeletal scaffolding protein highly expressed at pressure-bearing sites of the mammalian footpad, which can be induced in hyperproliferative states such as wound healing, inflammation, and cancer.

The investigators found that mice that had been genetically engineered to lack the iRHOM2 gene had abnormally thin paw skin, while humans with mutations that increased the expression of iRHOM2 had thickened palms and soles with callouses, and that a high percentage of these patients developed esophageal cancer.

At the molecular level, the investigators found that iRHOM2 bound to K16, and that this interaction was increased in TOC keratinocytes, where it was associated with robust downregulation of K16’s binding partner K6. In humans and mice, iRHOM2 loss resulted in dampened proliferation and reduced K16 expression, and in mice this led to thinning of epidermis in the footpad.

The authors concluded that, "These findings contribute to our understanding of the molecular mechanisms underlying hyperproliferation of the palmoplantar epidermis in both physiological and disease states, and how this "stress" keratin is regulated. These findings highlight a novel and fundamental role for iRHOM2 in regulating the epithelial response to mechanical stress."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.